Biotech · Private company · Canonsburg, PA, US
Mylan Inc.
SEC CIK 0000069499
Track this companyFree. Adds Mylan Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials230 recruiting or active
Pipeline programs34From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline34
- FlexPen NovoLog®Phase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- FormoterolPhase 3 · Chronic Obstructive Pulmonary Disease (COPD)ClinicalTrials.gov · fetched Nov 12, 2026
- Lantus®Phase 3 · Type 1 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Lantus®Phase 3 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Lantus®Phase 3 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- MYL-1501D product using manufacture process VPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- MYL-1501D product using manufacture process VIPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- MYL-1601D ProductPhase 3 · Diabetes Mellitus, Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- Mylan's insulin glarginePhase 3 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Mylan's insulin glarginePhase 3 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Mylan's insulin glarginePhase 3 · Type 1 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Pimecrolimus Cream, 1%Phase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- RevefenacinPhase 3 · Chronic Obstructive Pulmonary Disease, COPDClinicalTrials.gov · fetched Nov 12, 2026
- Spiriva Handihaler®Phase 3 · Chronic Obstructive Pulmonary Disease, COPDClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208Phase 3 · Chronic Obstructive Pulmonary Disease (COPD)ClinicalTrials.gov · fetched Nov 12, 2026
- TiotropiumPhase 3 · Chronic Obstructive Pulmonary Disease (COPD)ClinicalTrials.gov · fetched Nov 12, 2026
- MR-107A-01Phase 2 · PainClinicalTrials.gov · fetched Nov 12, 2026
- Permethrin Foam 4%Phase 2 · ScabiesClinicalTrials.gov · fetched Nov 12, 2026
- Permethrin Foam 5%Phase 2 · ScabiesClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208Phase 2 · COPDClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208Phase 2 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle FoamPhase 2 · ScabiesClinicalTrials.gov · fetched Nov 12, 2026
- Moxifloxacin 400 mgPhase 1 · Cardiac Repolarization in Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208Phase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208Phase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208 175 mcgPhase 1 · Cardiac Repolarization in Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- TD-4208 700 mcgPhase 1 · Cardiac Repolarization in Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Bethkis®Pseudomonas Aeruginosa in Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Cayston®Pseudomonas Aeruginosa in Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Sulfamylon® For 5 % Topical SolutionBurnsClinicalTrials.gov · fetched Nov 12, 2026
- Tobi PodhalerCystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- TOBI®Pseudomonas Aeruginosa in Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- TOBI® PODHALER®Pseudomonas Aeruginosa in Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Topical Antimicrobial/Antifungal MedicationsBurnsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials23
- Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 CyclesPHASE3 · COMPLETED · started Oct 26, 2021ClinicalTrials.gov NCT05139121 · fetched Nov 12, 2026
- Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental PainPHASE2 · COMPLETED · started Sep 29, 2020ClinicalTrials.gov NCT04571515 · fetched Nov 12, 2026
- Mylan Insulin Aspart StudyPHASE3 · COMPLETED · started Nov 7, 2018ClinicalTrials.gov NCT03760068 · fetched Nov 12, 2026
- Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo CapsulesPHASE4 · COMPLETED · started Jun 26, 2018ClinicalTrials.gov NCT03502070 · fetched Nov 12, 2026
- A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPDPHASE3 · COMPLETED · started May 31, 2018ClinicalTrials.gov NCT03573817 · fetched Nov 12, 2026
- Mylan Insulin Glargine StudyPHASE3 · COMPLETED · started Nov 29, 2017ClinicalTrials.gov NCT03376789 · fetched Nov 12, 2026
- Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPDPHASE3 · COMPLETED · started Mar 27, 2017ClinicalTrials.gov NCT03095456 · fetched Nov 12, 2026
- Thorough QT (TQT) Study of TD-4208 in Healthy SubjectsPHASE1 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02820311 · fetched Nov 12, 2026
- Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic DermatitisPHASE3 · COMPLETED · started Feb 29, 2016ClinicalTrials.gov NCT03107611 · fetched Nov 12, 2026
- Pharmacokinetics of TD-4208 in Patients With Severe Renal ImpairmentPHASE1 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02578082 · fetched Nov 12, 2026
- Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) PatientsPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02666430 · fetched Nov 12, 2026
- Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic ImpairmentPHASE1 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02581592 · fetched Nov 12, 2026
- Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)PHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02459080 · fetched Nov 12, 2026
- A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)PHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02518139 · fetched Nov 12, 2026
- Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)PHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02512510 · fetched Nov 12, 2026
- TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male SubjectsPHASE1 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02772159 · fetched Nov 12, 2026
- Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial DrugsCOMPLETED · started May 5, 2015ClinicalTrials.gov NCT02449031 · fetched Nov 12, 2026
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)PHASE3 · COMPLETED · started Aug 1, 2014ClinicalTrials.gov NCT02227875 · fetched Nov 12, 2026
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)PHASE3 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02227862 · fetched Nov 12, 2026
- A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)PHASE2 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02040792 · fetched Nov 12, 2026
- A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)PHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02109172 · fetched Nov 12, 2026
- A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of ScabiesPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02094716 · fetched Nov 12, 2026
- Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control GroupPHASE4 · TERMINATED · started Sep 1, 2007ClinicalTrials.gov NCT00634166 · fetched Nov 12, 2026